Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.833 USD | -7.96% | -5.86% | -34.74% |
Business Summary
Number of employees: 132
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Products fo Patients Treated by Ear, Nose and Throat and Allergy Specialists
100.0
%
| 76 | 100.0 % | 71 | 100.0 % | -6.93% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 76 | 100.0 % | 71 | 100.0 % | -6.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ramy Mahmoud
CEO | Chief Executive Officer | 59 | 09-12-31 |
Chief Tech/Sci/R&D Officer | - | 17-05-31 | |
John C. Messina
CTO | Chief Tech/Sci/R&D Officer | - | 09-12-31 |
Jonathan Neely
IRC | Investor Relations Contact | - | 17-11-30 |
Paul Spence
PRN | Corporate Officer/Principal | 56 | 22-12-14 |
Anthony Kirck
AUD | Comptroller/Controller/Auditor | 43 | 21-10-31 |
Ramona M. Lloyd
LAW | General Counsel | - | 14-06-11 |
Michael Marino
LAW | General Counsel | 48 | 16-12-31 |
Karen Brophy
HRO | Human Resources Officer | 60 | 18-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 17-09-30 | |
Sandra Helton
BRD | Director/Board Member | 74 | 18-02-21 |
Eric Bednarski
BRD | Director/Board Member | 53 | 21-12-09 |
R. Fletcher
CHM | Chairman | 78 | 22-04-25 |
Ramy Mahmoud
CEO | Chief Executive Officer | 59 | 09-12-31 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 20-11-30 |
Kyle Dempsey
BRD | Director/Board Member | 35 | 21-12-09 |
Catherine Owen
BRD | Director/Board Member | - | 20-07-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 112,651,740 | 102,546,895 ( 91.03 %) | 0 | 91.03 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.84% | 102M | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- OPTN Stock
- Company OptiNose, Inc.